pmc logo image
Logo of nihpaNIHPA bannerabout author manuscriptssubmit a manuscript

Formats:

J Am Chem Soc. Author manuscript; available in PMC 2009 June 11.
Published in final edited form as:
Published online 2008 May 20. doi: 10.1021/ja803012n.
PMCID: PMC2435505
NIHMSID: NIHMS54040
Total Synthesis of Cytotoxic Macrolide Amphidinolide B1 and the Proposed Structure of Amphidinolide B2
Liang Lu, Wei Zhang, and Rich G. Carter*
Department of Chemistry, Oregon State UniVersity, 153 Gilbert Hall, CorVallis, Oregon 97331
E-mail: rich.carter/at/oregonstate.edu
Amphidinolide B1 (1) and its C18 epimer amphidinolide B2 (2) have generated significant attention from the synthetic community1,2 because of their potent cytotoxic activity against several cancer cell lines. In fact, macrolide 1 is the most potent member of this family with a reported IC50 value of 0.14 ng/mL against L1210 murine leukemia cell line.3 Despite these efforts, their total syntheses remain elusive targets. Macrolides 1 and 2 represent considerable synthetic challenges because of their highly substituted C13–C15 diene functionality,1c,4 the densely functionalized C21–C26 right-hand portion, the labile C6–C9 epoxy alkene, and a 26-membered lactone. Our retrosynthetic strategy starts by disconnection at C8,9 to reveal the aldehydes 3 and 4 (Scheme 1Scheme 1). Further cleavage of the ester linkage at C25 would lead to the alcohols 5 and 6 and the keto phosphonate 7. The C18–C19 bond should be available via a diastereoselective aldol reaction with the aldehyde 8 and α-oxy ketone 9. We have previously reported a chelation strategy for the synthesis of the 18S stereochemistry present in amphidinolide B11b,c,5 and this approach has been used by others in the field,6 including Fürstner’s recent total syntheses of amphidinolide G and H.6a Herein, we report a nonchelation strategy for construction of the C18 stereochemistry and its application to the total syntheses of cytotoxic macrolide amphidinolide B1 (1) and the proposed structure of amphidinolide B2 (2).
Scheme 1
Scheme 1
Scheme 1
Retrosynthetic Analysis of Amphidinolide B2
Our syntheses of the aldehyde and methyl ketone subunits commenced with the previously reported intermediates 11 and 14 (Scheme 2Scheme 2).1a,c Conversion of the C9 nitrile 11 into the corresponding acetate 12 followed by selective functionalization of the C18,19 alkene using AD mix β* provided the C18,19 diol as an inconsequential 6:1 mixture of diastereomers.1c Cleavage of the resultant diol with sodium periodate provided the desired aldehyde 8. For the synthesis of the Eastern subunit 9, Horner–Wadsworth–Emmons olefination of aldehyde 14 followed by dihydroxylation yielded the diol 16. Next, bis-silylation followed by selective C25 TES deprotection yielded the free alcohol at C25. Finally, Mitsunobu inversion of the alcohol followed by saponification and TMS protection revealed the ketone 9.
Scheme 2
Scheme 2
Scheme 2
Synthesis of Western and Eastern Subunitsa
The key diastereoselective aldol coupling is shown in Scheme 3Scheme 3. Treatment of ketone 9 under our standard LDA, Et2O/THF conditions that proved effective with the C21 OPMB series1c resulted in low conversion and poor diastereoselectivity favoring the 18S stereochemistry [approximately 1.5:1 dr (5:6)]. Interestingly, addition of TMEDA led to a dramatic rate acceleration and a reversal of the selectivity [2:1 dr (6:5)]. Additional cooling of the reaction to −100 °C led to improved diastereoselectivity [8:1 dr (6:5)] in reasonable yield (65% overall). While we are still exploring the nature of the diastereoselectivity, one possible explanation could be a transition state which minimizes the dipoles of the C21 C–O σ bond and the enolate.7 The alternate 18S diastereomer can be obtained by performing the reaction at higher temperatures (−40 °C, 1.2:1 dr 5:6). Silyl protection of alcohols 5 and 6 separately using TESCl/DMAP yielded the silyl ether compounds 17 and 18, respectively.
Scheme 3
Scheme 3
Scheme 3
Key Diastereoselective Aldol Couplinga
With an effective strategy for the coupling of the Eastern and Western subunits in hand, we turned our attention to the key macrocyclization event (Scheme 4Scheme 4). We chose to initially explore this sequence on the 18R compound 18. TMS deprotection of silyl ether 18 at C25 and incorporation of the C1–C8 subunit provided the keto phosphonate 20.8 Removal of the C9 acetate followed by Ley’s TPAP oxidation revealed the target aldehyde 4. The corresponding aldehyde 4 proved to be highly reactive as attempted isolation led to considerable loss of material. Interestingly, significant amounts of the aldehyde 4, formed during the TPAP oxidation, appeared to undergo spontaneous intramolecular Wadsworth–Emmons olefination to provide the desired macrocycle 22. The conversion could be driven to completion by the addition of LiCl and Hunig’s base9 in 51% yield. A similar sequence was followed for construction of the 18S macrocycle 21. In this case, Ba(OH)2 proved more effective for driving the macrocyclization to completion. Additionally, we were pleased to observe that macrocycle 21 crystallized upon standing–allowing us to confirm the stereochemistry in 21.10
Scheme 4
Scheme 4
Scheme 4
Closure of the Macrocyclea
With an efficient route into the macrocycles 21 and 22, the final challenges were the incorporation of the C6–C9 allylic epoxide moiety and deprotection. As before, we explored the initial chemistry on the 18R macrolactone 22 (Scheme 5Scheme 5). Our previous experiences with deprotection of late stage amphidinolide B intermediates made us mindful of the difficulty of the final deprotection sequence.1d Regioselective and stereoselective reduction of the C7 carbonyl functionality could be accomplished with the (S)-CBS reagent.11 We next had intended to epoxidize the alkene under Sharpless conditions;12 however, the presumed steric congestion of the C7 alcohol thwarted this approach. Fortunately, use of Ti(Oi-Pr)4 and TBHP in the absence of DIPT led to formation of both the syn and anti diastereomer–favoring the syn stereochemistry (2:1 dr).13 As the syn diastereomer 24 contained the proposed stereochemistry in amphidinolide B2, we initially proceeded forward with that diastereomer. Selenide incorporation14 and elimination under our recently developed TPAP/NMO conditions1d,15 yielded the fully functionalized macrocycle. Unfortunately, all attempts to remove the silyl protecting groups under fluoride or acidic conditions led to decomposition. Suspecting that the allylic epoxide might be the culpable functionality, we next explored global deprotection on the epoxy selenide 26. We were quite pleased to find that treatment with TAS-F6a cleanly removed all silyl protecting groups to provide the polyol 28. The final selenide oxidation/syn elimination proved problematic under standard (H2O2) conditions. This issue was not completely surprising as we have previously encountered this problem in our azaspiracid work15 as well as a previous generation amphidinolide approach. 1d We have attributed this deleterious reactivity to the α-hydroxy ketone moiety. Although our TPAP/NMO conditions15 are not compatible with the polyol functionality of 28, we were gratified to find that bistrimethylsilylperoxide (TMSOOTMS) cleanly facilitated selenide oxidation with in situ syn elimination to reveal product 2. Surprisingly, this compound 2 did not match with the spectra data provided for the natural product amphidinolide B2.3 We followed a similar sequence to the C8, 9 epoxide diastereomer 30 which too did not correspond with the reported data for amphidinolide B2. In both cases, the 1H NMR shift for the H14 alkene was shifted significantly downfield as compared to the natural product data. Careful inspection of the isolation paper revealed that the stereochemical analysis of amphidinolide B2 was based primarily on the differences in the 1H NMR in the C17–C19 region of the natural product as compared to amphidinolide B1 (1).3b It is important to note that Shimizu and Clardy obtained X-ray crystallographic structure of natural product 1.3b It is clear from our work that the structural differences between amphidinolide B1 and B2 are more complicated than initially expected. On the basis of this information, we haVe concluded that the proposed structure of amphidinolide B2 is incorrect .
Scheme 5
Scheme 5
Scheme 5
Synthesis of Proposed Structure of Amphidinolide B2 and its C8,9 Diastereomera
Next, we shifted our focus to the total synthesis of amphidinolide B1 (1) (Scheme 6Scheme 6). We applied an analogous strategy for the synthesis of 1 as was described for the 18R series. It appears that a slight reversal in selectivity in the epoxidation occurs with the 18S stereochemistry–now with a modest preference for the undesired C8,9 epoxide. Fortunately, these diastereomers are chromatographically separable. Conversion of syn epoxide 32 to the selenide followed by TAS-F deprotection yielded the penultimate intermediate. Finally, we were grateful to find that tandem selenide oxidation/elimination using our bis-TMS peroxide conditions yielded the natural product amphidinolide B1 (1). The synthesized material 1 matched with the spectra data reported by Kobayashi and co-workers for amphidinolide B1.3c
Scheme 6
Scheme 6
Scheme 6
Total Synthesis of Amphidinolide B1a
In summary, the first total syntheses of amphidinolide B1 and the proposed structure of amphidinolide B2 have been achieved. The longest linear sequence is 25 steps from commercially available lactic acid. Determination of the actual structure of amphidinolide B2 will be reported in due course.
Acknowledgments
Financial support was provided by the National Institutes of Health (NIH) (Grant GM63723) and Oregon State University (OSU). The authors would like to thank Dr. Lev N. Zakharov (OSU and University of Oregon) for X-ray crystallographic analysis of compound 21, Professor Max Deinzer (OSU) and Dr. Jeff Morré (OSU) for mass spectra data, Rodger Kohnert (OSU) and Dr. Clemens Anklin (Brüker Biospin) for NMR assistance, and Dr. Roger Hanselmann (Rib-X Pharmaceuticals) for his helpful discussions.
Footnotes
Supporting Information Available: Complete experimental procedures are provided, including 1H and 13C spectra, of all new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.
1. (a) Zhafng W, Carter RG, Yokochi AFT. J Org Chem. 2004;69:2569–2572. [PubMed] (b) Carter RG, Zhang W. ORGN-398; 227th National Meeting of the American Chemical Society; Anaheim, CA. Washington, DC: American Chemical Society; 2004. [PubMed] (c) Zhang W, Carter RG. Org Lett. 2005;7:4209–4212. [PubMed] (d) Zhang W. Ph.D. Dissertation. Oregon State University; Oregon: 2006. [PubMed]
2. (a) Chakraborty TK, Thippewamy D, Suresh VR, Jayaprakash S Chem Lett. 1997:563–564. (b) Chakraborty TK, Suresh VR Chem Lett. 1997:565–566. (c) Lee DH, Lee S-W Tetrahedron Lett. 1997;38:7909–7910. (d) Ohi K, Shima K, Hamada K, Saito Y, Yamada N, Ohba S, Nishiyama S Bull Chem Soc Jpn. 1998;71:2433–2440. (e) Ohi K, Nishiyama S Synlett. 1999:571–572. (f) Ohi K, Nishiyama S Synlett. 1999:573–575. (g) Eng HM, Myles DC Tetrahedron Lett. 1999;40:2275–2278. (h) Eng HM, Myles DC Tetrahedron Lett. 1999;40:2279–2282. (i) Chakraborty TK, Thippewamy D Synlett. 1999:150–152. (j) Ishiyama H, Takemura T, Tsuda M, Kobayashi J J Chem Soc Perkin Trans 1. 1999:1163–1166. (k) Cid B, Pattenden G Tetrahedron Lett. 2000;41:2573–2576. (l) Ndubaku CO, Jamison TF ORGN-392; 227th National Meeting of the American Chemical Society; Anaheim, CA. Washington, DC: American Chemical Society; 2004. (m) Mandal AK, Schneekloth JS, Jr, Crews CM Org Lett. 2005;7:3645–3648. [PubMed] correction: Org Lett. 2006;7:5347–5348. (n) Gopalarathnam A, Nelson SG Org Lett. 2006;8:7–10. [PubMed] (o) Mandal AK, Schneekloth JS, Jr, Kuramochi K, Crews CM Org Lett. 2006;8:427–430. [PubMed]
3. (a) Ishibashi M, Ishiyama H, Kobayashi J. Tetrahedron Lett. 1994;35:8241–8242. [PubMed] (b) Bauer I, Maranda L, Shimizu Y, Peterson RW, Cornell L, Steiner JR, Clardy J. J Am Chem Soc. 1994;116:2657–658. [PubMed] (c) Tsuda M, Kubota T, Sakuma Y, Kobayashi J. Chem Pharm Bull. 2001;49:1366–1367. [PubMed]
4. The combination of the C16 tertiary alcohol with the highly substituted C13-C15 diene imparts a unique challenge because traditional cross coupling strategies for its formation have proven problematic. This key tertiary C16 alcohol is not present in amphidinolides G and H.
5. Chakraborty TK, Suresh VR. Tetrahedron Lett. 1998;39:7775–7778.
6. (a) Fürstner A, Bouchez LC, Funel J-A, Liepins V, Porée F-H, Gilmour R, Beaufils F, Laurich D, Tamiya M. Angew Chem Int Ed. 2007;46:9425–9430. (b) Deng L, Ma Z, Zhang Y, Zhao G. Synlett. 2007:87–90.
7. Figueras S, Martín R, Romea P, Urpí F, Vilarrasa J. Tetrahedron Lett. 1997;38:1637–1640.
8. The keto phosphonate 7 was prepared in four steps from the commercially available 5-hexenoic acid methyl ester. See the Supporting Information for complete details.
9. Blanchette MA, Choy W, Davis JT, Essenfeld AP, Masamune S, Roush WR, Sakai T. Tetrahedron Lett. 1984;25:2183–2186.
10. See Supporting Information for ORTEP representation and CIF data of 21.
11. (a) Corey EJ, Bakshi RK, Shibata S, Chen CP, Singh VK. J Am Chem Soc. 1987;109:7925–7926. (b) Mathre DJ, Jones TK, Xavier LC, Blacklock TJ, Reamer RA, Mohan JJ, Jones ETT, Hoogsteen K, Baum MW, Grabowski EJJ. J Org Chem. 1991;56:751–762.
12. Krishna PR, Lopinti KR, Kannan V. Tetrahedron Lett. 2004;45:7847–7850.
13. Relative stereochemical assignments are based on literature precedent. We cannot at this time rigorously establish the relative stereochemistries of these two epoxy alcohols Lurain AE, Carroll PJ, Walsh PJ J Org Chem. 2005;70:1262–1268. [PubMed]
14. Grieco PA, Gilman S, Nishizawa M. J Org Chem. 1976;41:1485–1486.
15. Zhou X-T, Carter RG. Angew Chem Int Ed. 2006;45:7622–7626.

See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph
See more articles cited in this paragraph